(Q28116089)

English

Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa

scientific journal article

In more languages

Statements

scholarly article

1 reference

PubMed publication ID

4 January 2017

Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa (English)

1 reference

PubMed publication ID

4 January 2017

coagulation factor IX

1 reference

GOA release 2020-03-11

Coagulation factor III, tissue factor

1 reference

GOA release 2020-03-11

coagulation factor VII

1 reference

GOA release 2020-03-11

blood coagulation

1 reference

GOA release 2020-03-11

author name string

P. J. Larson

1

1 reference

PubMed publication ID

4 January 2017

S. A. Stanfield-Oakley

2

1 reference

PubMed publication ID

4 January 2017

W. J. VanDusen

3

1 reference

PubMed publication ID

4 January 2017

C. K. Kasper

4

1 reference

PubMed publication ID

4 January 2017

K. J. Smith

5

1 reference

PubMed publication ID

4 January 2017

D. M. Monroe

6

1 reference

PubMed publication ID

4 January 2017

K. A. High

7

1 reference

PubMed publication ID

4 January 2017

language of work or name

0 references

publication date

16 February 1996

1 reference

PubMed publication ID

4 January 2017

Journal of Biological Chemistry

1 reference

PubMed publication ID

4 January 2017

271

1 reference

PubMed publication ID

4 January 2017

7

1 reference

PubMed publication ID

4 January 2017

3869–3876

1 reference

PubMed publication ID

4 January 2017

Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Nucleotide sequence of the gene for human factor IX (antihemophilic factor B)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Haemophilia B: database of point mutations and short additions and deletions--fourth edition, 1993

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Monoclonal antibodies to factor IX: characterization and use in immunoassays for factor IX.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Electroimmunoassay of factor IX in hemophilia B

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Occurrence of beta-hydroxylated asparagine residues in non-vitamin K-dependent proteins containing epidermal growth factor-like domains

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Measurement of human factor IXa activity in an isolated factor X activation system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Factor IX Kawachinagano: impaired function of the Gla-domain caused by attached propeptide region due to substitution of arginine by glutamine at position -4.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Defective propeptide processing of blood clotting factor IX caused by mutation of arginine to glutamine at position -4.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Molecular cloning of matrix Gla protein: implications for substrate recognition by the vitamin K-dependent gamma-carboxylase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Molecular defects in haemophilia B: detection by direct restriction enzyme analysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Recognition site directing vitamin K-dependent gamma-carboxylation resides on the propeptide of factor IX

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

The kinetic assembly of the intrinsic bovine factor X activation system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Propeptide of human protein C is necessary for .gamma.-carboxylation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.7.3869

21 January 2018

Identifiers

10.1074/JBC.271.7.3869

0 references

PubMed publication ID

1 reference

PubMed publication ID

4 January 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28116089&oldid=1458407764"